{
 "PrintNo":"A2163","Session":2023,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2023-01-23T12:50:49.147332Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2024-01-03","Committee":"Insurance"}],
 "Actions":[
  {"Text":"REFERRED TO INSURANCE","Date":"2023-01-23","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO INSURANCE","Date":"2024-01-03","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":520,"Name":"Linda Rosenthal","Short":"ROSENTHAL L"}],
 "Title":"Establishes patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy",
 "Summary":"Establishes patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy; prohibits certain \"brown bagging\" and \"white bagging\" policies regarding pharmacy provided medications.",
 "LawSection":"Insurance Law","LawCode":"Amd §§3217-b & 4325, Ins L; amd §4406-c, Pub Health L",
 "ActClause":"AN ACT to amend the insurance law and the public health law, in relation to establishing patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy",
 "SameAsPrintNo":"S7413-2023","PreviousVersions":["A9516-2021"]
}